Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
Identifieur interne : 000143 ( Ncbi/Checkpoint ); précédent : 000142; suivant : 000144Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
Auteurs : Suzanne L. Epstein [États-Unis]Source :
- The Journal of infectious diseases [ 0022-1899 ] ; 2006.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Dossiers médicaux, Enfant, Enfant d'âge préscolaire, Flambées de maladies, Grippe humaine (immunologie), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains, Nourrisson, Nouveau-né, Ohio (épidémiologie), Réactions croisées, Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H2N2 du virus de la grippe A (pathogénicité), Surveillance de la population.
- MESH :
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A.
- pathogénicité : Sous-type H2N2 du virus de la grippe A.
- virologie : Grippe humaine.
- épidémiologie : Grippe humaine, Ohio.
- Adolescent, Adulte, Adulte d'âge moyen, Dossiers médicaux, Enfant, Enfant d'âge préscolaire, Flambées de maladies, Humains, Nourrisson, Nouveau-né, Réactions croisées, Surveillance de la population.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, Cross Reactions, Disease Outbreaks, Humans, Infant, Infant, Newborn, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H2N2 Subtype (pathogenicity), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (virology), Medical Records, Middle Aged, Ohio (epidemiology), Population Surveillance.
- MESH :
- geographic , epidemiology : Ohio.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- pathogenicity : Influenza A Virus, H2N2 Subtype.
- virology : Influenza, Human.
- Adolescent, Adult, Child, Child, Preschool, Cross Reactions, Disease Outbreaks, Humans, Infant, Infant, Newborn, Medical Records, Middle Aged, Population Surveillance.
Abstract
During a pandemic, influenza vaccines that rely on neutralizing antibodies to protect against matched viruses might not be available early enough. Much broader (heterosubtypic) immune protection is seen in animals. Do humans also have cross-subtype immunity? To investigate this issue, archival records from the Cleveland Family Study, which was conducted before and during the 1957 pandemic (during which a shift from subtype H1N1 to H2N2 occurred), were analyzed. Only 5.6% of the adults who had had symptomatic influenza A in earlier study years developed influenza during the pandemic, despite living in households with participants who had influenza. In contrast, 55.2% of the children who had had symptomatic influenza A contracted it again. These findings suggest an impact of accumulated heterosubtypic immunity during a pandemic. Such immunity, as well as its implications for vaccination, should be further investigated.
DOI: 10.1086/498980
PubMed: 16323131
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000313
- to stream PubMed, to step Curation: 000313
- to stream PubMed, to step Checkpoint: 000269
- to stream Ncbi, to step Merge: 000143
- to stream Ncbi, to step Curation: 000143
Links to Exploration step
pubmed:16323131Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.</title><author><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L" last="Epstein">Suzanne L. Epstein</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. epsteins@cber.fda.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852</wicri:regionArea><wicri:noRegion>MD 20852</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16323131</idno><idno type="pmid">16323131</idno><idno type="doi">10.1086/498980</idno><idno type="wicri:Area/PubMed/Corpus">000313</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000313</idno><idno type="wicri:Area/PubMed/Curation">000313</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000313</idno><idno type="wicri:Area/PubMed/Checkpoint">000269</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000269</idno><idno type="wicri:Area/Ncbi/Merge">000143</idno><idno type="wicri:Area/Ncbi/Curation">000143</idno><idno type="wicri:Area/Ncbi/Checkpoint">000143</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.</title><author><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L" last="Epstein">Suzanne L. Epstein</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. epsteins@cber.fda.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852</wicri:regionArea><wicri:noRegion>MD 20852</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="ISSN">0022-1899</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cross Reactions</term><term>Disease Outbreaks</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza A Virus, H2N2 Subtype (pathogenicity)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (virology)</term><term>Medical Records</term><term>Middle Aged</term><term>Ohio (epidemiology)</term><term>Population Surveillance</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Dossiers médicaux</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Flambées de maladies</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Nourrisson</term><term>Nouveau-né</term><term>Ohio (épidémiologie)</term><term>Réactions croisées</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sous-type H2N2 du virus de la grippe A (pathogénicité)</term><term>Surveillance de la population</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ohio</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H2N2 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H2N2 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Ohio</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Cross Reactions</term><term>Disease Outbreaks</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Medical Records</term><term>Middle Aged</term><term>Population Surveillance</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Dossiers médicaux</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Flambées de maladies</term><term>Humains</term><term>Nourrisson</term><term>Nouveau-né</term><term>Réactions croisées</term><term>Surveillance de la population</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">During a pandemic, influenza vaccines that rely on neutralizing antibodies to protect against matched viruses might not be available early enough. Much broader (heterosubtypic) immune protection is seen in animals. Do humans also have cross-subtype immunity? To investigate this issue, archival records from the Cleveland Family Study, which was conducted before and during the 1957 pandemic (during which a shift from subtype H1N1 to H2N2 occurred), were analyzed. Only 5.6% of the adults who had had symptomatic influenza A in earlier study years developed influenza during the pandemic, despite living in households with participants who had influenza. In contrast, 55.2% of the children who had had symptomatic influenza A contracted it again. These findings suggest an impact of accumulated heterosubtypic immunity during a pandemic. Such immunity, as well as its implications for vaccination, should be further investigated.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Epstein, Suzanne L" sort="Epstein, Suzanne L" uniqKey="Epstein S" first="Suzanne L" last="Epstein">Suzanne L. Epstein</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000143 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000143 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:16323131
|texte= Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:16323131" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |